Alper Sonmez

Guven, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Polypharmacy and associated factors in patients with type 2 diabetes: a nationwide cross-sectional study (TEMD-2 polypharmacy study).

Polypharmacy and associated factors in patients with type 2 diabetes: a nationwide cross-sectional study (TEMD-2 polypharmacy study).

Journal: Postgraduate medicine

Published: May 14, 2026

Reply to the Letter to the Editor: Two Overlooked Issues in Hypertension Management: Risk Thresholds and Obesity Integration.

Reply to the Letter to the Editor: Two Overlooked Issues in Hypertension Management: Risk Thresholds and Obesity Integration.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: May 07, 2026

The Turkish Hypertension Consensus Report 2025

The Turkish Hypertension Consensus Report 2025

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: March 25, 2026

The Turkish Hypertension Consensus Report 2025

The Turkish Hypertension Consensus Report 2025

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: March 25, 2026

Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study).

Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study).

Journal: Journal of diabetes and its complications

Published: February 17, 2026

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Journal: Obesity facts

Published: February 11, 2026

Suboptimal LDL-Cholesterol Control Under the 2019 ESC/EAS Dyslipidemia Guidelines: Results From the Nationwide TEMD-2 Study in Type 2 Diabetes.

Suboptimal LDL-Cholesterol Control Under the 2019 ESC/EAS Dyslipidemia Guidelines: Results From the Nationwide TEMD-2 Study in Type 2 Diabetes.

Journal: Diabetes, obesity & metabolism

Published: December 31, 2025

Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study.

Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study.

Journal: Archives of osteoporosis

Published: September 01, 2025

Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study).

Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study).

Journal: Journal of clinical medicine

Published: August 08, 2025

Risk factors associated with gestational transient thyrotoxicosis and their effects on the pregnancy course.

Risk factors associated with gestational transient thyrotoxicosis and their effects on the pregnancy course.

Journal: Archives of endocrinology and metabolism

Published: April 08, 2025

Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study.

Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study.

Journal: European journal of medical research

Published: March 12, 2025

Impact of Obesity on Metabolic Control in Type 2 Diabetes: Five-Year Trends of Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes (TEMD Obesity Study, 2017-2022).

Impact of Obesity on Metabolic Control in Type 2 Diabetes: Five-Year Trends of Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes (TEMD Obesity Study, 2017-2022).

Journal: Obesity facts

Published: January 28, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026